✦ LIBER ✦
597 ORAL A randomised phase III multicenter trial comparing irinotecan in combination with either the Nordic bolus 5FU and folinic acid (5FU/FA) schedule (FLIRI) or the bolus/infused de Gramont schedule (FOLFIRI), in patients with metastatic colorectal cancer
- Book ID
- 118623174
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 131 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.